IL-10 induction from implants delivering pancreatic islets and hyaluronan

Area of Science:

• Immunology
• Biomaterials Science
• Transplantation Biology

Background:

• Local induction of pro-tolerogenic cytokines like Interleukin-10 (IL-10) is crucial for successful tissue transplantation.
• Hyaluronan (HA) has been identified as a promoter of IL-10 production by activated T cells.
• Developing effective strategies to enhance immune tolerance is essential for improving graft survival in conditions like type 1 diabetes.

Purpose of the Study:

• To design and evaluate novel implantable devices for local induction of IL-10 production.
• To leverage the immunomodulatory properties of hyaluronan (HA) in combination with biomaterial scaffolds.
• To establish model systems for future studies aimed at improving islet transplant outcomes.

Main Methods:

• Development of an injectable HA-based hydrogel loaded with antibodies (anti-CD3/anti-CD28) and IL-2, embedding T cells for in vivo IL-10 production.
• Construction of a bioengineered implant with a polyvinyl alcohol sponge scaffold, collagen hydrogel, and alginate spheres for sustained HA release.
• Implantation of ovalbumin (OVA)-expressing pancreatic islets into immunodeficient mice with OVA-specific T cells, followed by OVA peptide immunization and assessment of splenocyte responses.

Main Results:

• T cells embedded in the HA hydrogel demonstrated in vivo IL-10 production.
• Splenocytes from mice receiving the bioengineered implant and OVA challenge produced IL-10 upon re-challenge.
• Both device systems showed potential for HA-mediated IL-10 induction.

Conclusions:

• Two novel implantable devices utilizing hyaluronan (HA) have been developed to induce local IL-10 production.
• These systems demonstrate the potential of HA-based strategies for promoting immune tolerance in transplantation.
• Further research using these models aims to enhance the survival and function of transplanted islets, particularly for type 1 diabetes treatment.